| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/23/2013 | CN103356489A Proton pump inhibitor enteric coated pellet and preparation and preparation method thereof |
| 10/23/2013 | CN103356488A Capecitabine granule and preparation method thereof |
| 10/23/2013 | CN103356487A Adding method of granule flavor |
| 10/23/2013 | CN103356485A Hirudin albumin nanoparticles and preparation method thereof |
| 10/23/2013 | CN103356484A Magnetic solid "dextran-MLDH-fluorouracil" liposome |
| 10/23/2013 | CN103356483A Dextran-MLDH-fluorouracil super-molecular skeleton magnetic liposome |
| 10/23/2013 | CN103356482A Transpulmonary liposome for controlling drug transport |
| 10/23/2013 | CN103356481A Ophthalmic emulsions containing immunosuppressive agent |
| 10/23/2013 | CN103356480A Oleanolic acid nanometer suspension and preparation method thereof |
| 10/23/2013 | CN103356479A Moxifloxacin hydrochloride injection aqua |
| 10/23/2013 | CN103356478A 一种布洛芬注射液组合物及其制备方法 An injection fluid composition and preparation method ibuprofen |
| 10/23/2013 | CN103356476A Method for dissolving flavonoid compounds, carbon glycoside compounds or stilbene compounds and preparation method of injection or injectable powder injection |
| 10/23/2013 | CN102846570B Cefditoren pivoxil composition tablets and preparation method thereof |
| 10/23/2013 | CN102702092B Eutectic of two curcumin organic medicaments and preparation method thereof |
| 10/23/2013 | CN102665763B Film coating agent for solid preparation, and solid preparation using same |
| 10/23/2013 | CN102643346B Antibiotic containing antibody simulant and pharmacy application for same |
| 10/23/2013 | CN102641506B Bivalirudin-polyethylene glycol compound |
| 10/23/2013 | CN102600072B Tirofiban hydrochloride injecta and preparation method thereof |
| 10/23/2013 | CN102600063B Method for preparing curcumin micelle with high medicine loading |
| 10/23/2013 | CN102585258B Gelatin embolism microsphere and preparation method and application thereof |
| 10/23/2013 | CN102579322B Externally applied hydrogel agent and preparation method and application thereof |
| 10/23/2013 | CN102516395B Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof |
| 10/23/2013 | CN102512394B Nifedipine sustained release tablets and preparation process thereof |
| 10/23/2013 | CN102512377B Tasteless quick-releasing berberine hydrochloride pellet |
| 10/23/2013 | CN102504046B Amphipathy polyethylene glycol stem grafting chitosan copolymer and preparation method and application thereof |
| 10/23/2013 | CN102429825B Natural biomineralization powder, preparation method thereof and application thereof |
| 10/23/2013 | CN102247326B Oral chronopharmacologic drug delivery mini-pill preparation of propranolol and its salts |
| 10/23/2013 | CN102083414B Composition comprising antibiotic and corticosteroid |
| 10/23/2013 | CN101985044B Taste-masking medicinal coating composition |
| 10/23/2013 | CN101965201B Intralymphatic chemotherapy drug carriers |
| 10/23/2013 | CN101919822B Tablet with improved combination properties and preparation method thereof |
| 10/23/2013 | CN101906158B Pegylation hypoglycemic polypeptide and preparation method and application thereof |
| 10/23/2013 | CN101837130B Polyethylene glycol-dipeptide-antitumour drug complex and use thereof |
| 10/23/2013 | CN101677943B Multi-dose concentrate esmolol with benzyl alcohol |
| 10/23/2013 | CN101631564B Stabilization of vitamin B12 |
| 10/23/2013 | CN101583339B Compositions comprising macromolecular assemblies of lipid and surfactant |
| 10/23/2013 | CN101346397B Agents that bind target in pulmonary tissue for treating respiratory diseases |
| 10/22/2013 | US8563682 Guanylylcyclase C ligands |
| 10/22/2013 | US8563651 Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol) |
| 10/22/2013 | US8563618 Skin external preparation having excellent stability |
| 10/22/2013 | US8563613 Diclofenac topical formulation |
| 10/22/2013 | US8563520 Treatment of ocular disease with inhibitors of alpha2 macroglobulin protein |
| 10/22/2013 | US8563514 Peptides and pharmaceutical compositions for treating connective tissue |
| 10/22/2013 | US8563042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 10/22/2013 | US8563039 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions |
| 10/22/2013 | US8563029 Exopolysaccharide containing food |
| 10/22/2013 | US8563028 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 10/22/2013 | US8563011 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 10/22/2013 | US8563005 Actinobacillus suis antigens |
| 10/22/2013 | US8562998 Targeting of antigen presenting cells with immunonanotherapeutics |
| 10/22/2013 | US8562975 Method for stabilizing reduced coenzyme Q10 and composition therefor |
| 10/22/2013 | US8562967 Stable liquid formulations of G-CSF |
| 10/22/2013 | US8562966 End-modified poly(beta-amino esters) and uses thereof |
| 10/22/2013 | US8562965 Polymer derivatives comprising an acetal or ketal branching point |
| 10/22/2013 | US8562964 Polymalic acid-based multifunctional drug delivery system |
| 10/22/2013 | CA2621377C Antitumor agent |
| 10/22/2013 | CA2602776C Method for treating prostate diseases based on local delivery of active substances |
| 10/22/2013 | CA2554089C Albumin fusion proteins |
| 10/22/2013 | CA2474344C Expansion of renewable stem cell populations |
| 10/22/2013 | CA2473526C Polyalkylene polymer compounds and uses thereof |
| 10/22/2013 | CA2424001C Oral preparations with favorable disintegration characteristics |
| 10/17/2013 | WO2013155487A1 Vehicles for controlled delivery of different pharmaceutical agents |
| 10/17/2013 | WO2013155463A1 Low band gap conjugated polymeric compositions and applications thereof |
| 10/17/2013 | WO2013155404A1 Methods and compositions for preparing a silk microsphere |
| 10/17/2013 | WO2013155173A2 Methods and compositions relating to biodegradable epoxy elastomers |
| 10/17/2013 | WO2013155134A1 Non-immunogenic delivery vehicle for beta-, gamma-, and delta- tocopherols and methods of using and making same |
| 10/17/2013 | WO2013154980A1 Composition comprising an organic diluent and a cellulose ether |
| 10/17/2013 | WO2013154977A1 Novel sustained release dosage forms |
| 10/17/2013 | WO2013154744A1 Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction |
| 10/17/2013 | WO2013154736A1 Ret2ir conjugates, ret2ir conjugate systems and methods of use thereof |
| 10/17/2013 | WO2013154707A1 Co-polymer conjugates |
| 10/17/2013 | WO2013154607A1 Esterified cellulose ethers having a specific substituent distribution |
| 10/17/2013 | WO2013154390A1 Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same |
| 10/17/2013 | WO2013154359A1 Nano-emulsion composition and method for producing the same |
| 10/17/2013 | WO2013154290A1 Ceria nanocomplex, pharmaceutical composition comprising said ceria nanocomplex, and method for preparing same |
| 10/17/2013 | WO2013154045A1 Composition for injectable solution |
| 10/17/2013 | WO2013153559A1 Fulvestrant formulations |
| 10/17/2013 | WO2013153550A2 Reverse thermal hydrogel preparations for use in the treatment of disorders of the urothelium |
| 10/17/2013 | WO2013153221A1 Vesicular formulations for use in the treatment of pain or reduced mobility of a joint |
| 10/17/2013 | WO2013153210A1 Sustained-release formulation |
| 10/17/2013 | WO2013153197A1 Ultrafine nanoparticles as multimodal contrast agent |
| 10/17/2013 | WO2013152838A1 Preparation for topical application to mucosa containing polyhexanide as active ingredient |
| 10/17/2013 | WO2013152590A1 Metal-polysaccharide conjugates: compositions,synthesis and methods for cancer therapy |
| 10/17/2013 | WO2013152418A1 System and method for multiphasic release of growth factors |
| 10/17/2013 | WO2013104995A3 Compositions and methods for treating viral infections |
| 10/17/2013 | US20130274689 Method for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor |
| 10/17/2013 | US20130274438 Analogs of ShK Toxin and Their Uses in Selective Inhibition of Kv1.3 Potassium Channels |
| 10/17/2013 | US20130274349 Open-celled foam with superabsorbent material and process for making the same |
| 10/17/2013 | US20130274343 Water Soluble Composition Comprising Curcumin Having Enhanced Bioavailability and Process Thereof |
| 10/17/2013 | US20130274341 Methods and Compositions for Treatment of Dermal Conditions |
| 10/17/2013 | US20130274340 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 10/17/2013 | US20130274324 Compositions of fat-soluble active ingredients containing plant protein-soy polysaccharide complexes |
| 10/17/2013 | US20130274309 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 10/17/2013 | US20130274296 Remelted ingestible products |
| 10/17/2013 | US20130274236 Fulvestrant compositions and methods of use |
| 10/17/2013 | US20130274229 Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| 10/17/2013 | US20130274226 Silica nanoparticle agent conjugates |
| 10/17/2013 | US20130274217 Controlled Release Formulations for the Delivery of HIF-1 Inhibitors |
| 10/17/2013 | US20130274211 Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions |
| 10/17/2013 | US20130274209 Sprayable pharmaceutical compositions for topical application comprising sucralfate gel |